mefruside has been researched along with Diseases, Metabolic in 1 studies
Mefruside: A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, C | 1 |
| Hunneman, DH | 1 |
| Scheler, F | 1 |
1 other study available for mefruside and Diseases, Metabolic
| Article | Year |
|---|---|
[Hyperreninism without hyperaldosteronism in diuretic abuse: a report of a case with identification of mefruside and ethacrynic acid in urine (author's transl)].
Topics: Aldosterone; Diuretics; Ethacrynic Acid; Female; Humans; Hypokalemia; Mefruside; Metabolic Diseases; | 1977 |